# 2seventy bio, Inc.

2seventy bio, Inc. is a company headquartered in Cambridge, MA, United States.

## Company overview

- **Legal name:** 2seventy bio, Inc.
- **Classification:** Company
- **Industry (SIC):** 2834 — Pharmaceutical Preparations
- **Headquarters:** Cambridge, MA, United States
- **Incorporated in:** DE
- **Fiscal year end:** December 31
- **SEC CIK:** 0001860782

## About

2seventy bio, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001860782, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-03-25, it reported annual revenue of USD 37,862,000; net income of USD -57,247,000; total assets of USD 479,510,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2024 (period ended 2024-12-31)

- **Revenue:** $37.9M (USD 37,862,000)
- **Net income:** -$57.2M (USD -57,247,000)
- **Total assets:** $479.5M (USD 479,510,000)
- **Cash and equivalents:** $71.2M (USD 71,244,000)
- **Operating cash flow:** -$85.0M (USD -84,998,000)

### FY2023 (period ended 2023-12-31)

- **Revenue:** $100.4M (USD 100,387,000)
- **Net income:** -$217.6M (USD -217,570,000)
- **Total assets:** $565.4M (USD 565,426,000)
- **Cash and equivalents:** $75.0M (USD 74,958,000)
- **Operating cash flow:** -$166.9M (USD -166,858,000)

### FY2022 (period ended 2022-12-31)

- **Revenue:** $91.5M (USD 91,496,000)
- **Net income:** -$254.2M (USD -254,153,000)
- **Total assets:** $656.7M (USD 656,665,000)
- **Cash and equivalents:** $71.0M (USD 71,032,000)
- **Operating cash flow:** -$237.1M (USD -237,134,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

### FY2021 (period ended 2021-12-31)

- **Revenue:** $54.5M (USD 54,522,000)
- **Net income:** -$292.2M (USD -292,213,000)
- **Total assets:** $759.7M (USD 759,675,000)
- **Cash and equivalents:** $130.4M (USD 130,414,000)
- **Operating cash flow:** -$207.0M (USD -207,034,000)
- **Later filings:** Operating cash flow: shown as originally filed; later filings report different values for the same periods.

## Recent SEC filings

- Form 8-K — filed 2025-05-13 — period 2025-05-13 — FORM 8-K
- Form 10-Q — filed 2025-05-07 — period 2025-03-31 — 10-Q
- Form 8-K — filed 2025-05-07 — period 2025-05-07 — 8-K
- Form 10-K/A — filed 2025-04-28 — period 2024-12-31 — 10-K/A
- Form 10-K — filed 2025-03-25 — period 2024-12-31 — 10-K
- Form 8-K — filed 2025-03-25 — period 2025-03-25 — 8-K
- Form 8-K — filed 2025-03-11 — period 2025-03-10 — 8-K
- Form 8-K — filed 2025-02-06 — period 2025-02-06 — 8-K
- Form 8-K — filed 2025-01-10 — period 2025-01-06 — 8-K
- Form 10-Q — filed 2024-11-12 — period 2024-09-30 — 10-Q
- Form 8-K — filed 2024-11-12 — period 2024-11-12 — 8-K
- Form 8-K — filed 2024-10-31 — period 2024-10-31 — 8-K

---

Updated: 2026-10-23T20:08:00Z

Canonical page: https://altss.com/profile/2seventy-bio-inc

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology